Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 802.27M | 782.12M | 557.72M | 388.83M | 259.75M | 156.62M |
Gross Profit | 394.98M | 391.55M | 276.21M | 183.62M | 114.86M | 69.60M |
EBITDA | 172.44M | 180.42M | 126.99M | 74.38M | 41.05M | 22.55M |
Net Income | 106.57M | 103.63M | 77.35M | 39.26M | 37.76M | 18.78M |
Balance Sheet | ||||||
Total Assets | 1.93B | 1.86B | 1.49B | 1.24B | 1.05B | 341.26M |
Cash, Cash Equivalents and Short-Term Investments | 492.76M | 444.10M | 283.93M | 338.65M | 592.05M | 100.00M |
Total Debt | 237.14M | 188.78M | 99.10M | 79.50M | 39.14M | 50.01M |
Total Liabilities | 778.41M | 759.82M | 564.75M | 423.33M | 240.51M | 133.09M |
Stockholders Equity | 949.15M | 904.63M | 767.39M | 674.86M | 676.20M | 141.15M |
Cash Flow | ||||||
Free Cash Flow | 92.40M | 69.99M | -139.66M | -154.71M | -49.80M | -69.03M |
Operating Cash Flow | 166.78M | 152.45M | -75.32M | -62.19M | -40.09M | -13.55M |
Investing Cash Flow | -40.49M | -11.96M | -6.75M | -265.67M | -11.28M | -69.95M |
Financing Cash Flow | 132.84M | 92.48M | 18.53M | 45.87M | 538.77M | 32.83M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $1.79B | 18.24 | 12.21% | ― | 26.21% | 17.34% | |
74 Outperform | $1.16B | 10.35 | 11.23% | ― | -3.19% | -11.06% | |
72 Outperform | $1.24B | 20.05 | 8.68% | ― | 3.30% | ― | |
70 Outperform | $2.44B | 25.90 | 12.33% | 2.75% | 10.78% | 58.82% | |
68 Neutral | $1.09B | 40.34 | 3.30% | ― | 20.20% | ― | |
57 Neutral | $745.52M | ― | -2.35% | ― | 13.41% | 72.56% | |
50 Neutral | C$2.97B | 1.83 | -63.12% | 2.59% | 11.24% | -12.42% |
On June 28, 2025, ACM Research (Shanghai), Inc. received approval from the China Securities Regulatory Commission for a private offering of ordinary shares to qualified buyers. The offering, which can proceed within 12 months, involves issuing up to 44.1 million shares, potentially raising RMB 4.5 billion (approximately $625 million), reflecting updates from recent employee stock option exercises.
The most recent analyst rating on (ACMR) stock is a Buy with a $23.00 price target. To see the full list of analyst forecasts on ACM Research stock, see the ACMR Stock Forecast page.
On June 12, 2025, ACM Research held its Annual Meeting of Stockholders where holders of Class A and Class B common stock voted on two key proposals. The stockholders elected four nominees to the board of directors and ratified the appointment of Ernst & Young Hua Ming LLP as the independent auditor for the fiscal year ending December 31, 2025.
The most recent analyst rating on (ACMR) stock is a Buy with a $23.00 price target. To see the full list of analyst forecasts on ACM Research stock, see the ACMR Stock Forecast page.
On June 12, 2025, ACM Research (Shanghai), Inc., a subsidiary of ACM Research, Inc., held its Annual Stockholder Meeting in Shanghai, China, where stockholders approved a proposed dividend of approximately RMB 288.3 million and a 2025 financial budget plan forecasting revenue growth of 16%-26% and R&D expense growth of 15%-35%. The dividend payment, expected by the end of 2025, may impact the company’s operations and financial results, as ACM Shanghai contributes a substantial majority of the consolidated revenue and net income of ACM Research, Inc.
The most recent analyst rating on (ACMR) stock is a Buy with a $23.00 price target. To see the full list of analyst forecasts on ACM Research stock, see the ACMR Stock Forecast page.
ACM Research (Shanghai), Inc. held an earnings call on May 15, 2025, discussing its first-quarter performance and future prospects. The company reported strong sales of its 3D stacking electroplating systems and sulfuric acid cleaning equipment, highlighting their competitive advantages and localization efforts in China. ACM Shanghai also announced plans to expand its global footprint, particularly in the semiconductor industry, with innovative products like the PECVD system and panel-level horizontal electroplating equipment. The company projects significant revenue growth in 2025, driven by its differentiated technologies and strategic focus on customer value creation.
The most recent analyst rating on (ACMR) stock is a Buy with a $38.00 price target. To see the full list of analyst forecasts on ACM Research stock, see the ACMR Stock Forecast page.
On April 18, 2025, Chenming C. Hu, a member of the Board of Directors of ACM Research, Inc., announced his decision not to stand for reelection at the 2025 Annual Meeting of Stockholders. Dr. Hu’s decision was not due to any disagreement with the company’s operations, policies, or practices, and he will continue to serve until the end of his term at the 2025 meeting.